Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | L-685458 | CTRPv2 | pan-cancer | AAC | 0.0029 | 0.9 |
mRNA | myricetin | CTRPv2 | pan-cancer | AAC | -0.003 | 0.9 |
mRNA | isoliquiritigenin | CTRPv2 | pan-cancer | AAC | -0.0048 | 0.9 |
mRNA | Crizotinib | GDSC1000 | pan-cancer | AAC | -0.0037 | 0.9 |
mRNA | COL-3 | CTRPv2 | pan-cancer | AAC | -0.0026 | 0.9 |
mRNA | C6-ceramide | CTRPv2 | pan-cancer | AAC | -0.0025 | 0.9 |
mRNA | ML210 | CTRPv2 | pan-cancer | AAC | 0.0022 | 0.9 |
mRNA | HG-5-113-01 | GDSC1000 | pan-cancer | AAC | -0.0029 | 0.9 |
mRNA | KIN001-055 | GDSC1000 | pan-cancer | AAC | -0.0021 | 0.9 |
mRNA | ML239 | CTRPv2 | pan-cancer | AAC | 0.0022 | 0.9 |